Advertisement
Screener

VYOME HOLDINGS, INC. (HIND) Increase (Decrease) in Deferred Revenue

2.8 / 5 stars · 68/120 Roast Me

VYOME HOLDINGS, INC. Increase (Decrease) in Deferred Revenue

VYOME HOLDINGS, INC. (HIND) reported Increase (Decrease) in Deferred Revenue of $72.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2020-02-27

  • VYOME HOLDINGS, INC. increase (decrease) in deferred revenue for the quarter ending 2018-03-31 was -$173.00K, a 446.00% decline year-over-year.
  • VYOME HOLDINGS, INC. increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was $317.00K, a 161.98% increase year-over-year.
  • VYOME HOLDINGS, INC. increase (decrease) in deferred revenue for the quarter ending 2017-09-30 was -$13.00K.
  • VYOME HOLDINGS, INC. increase (decrease) in deferred revenue for the quarter ending 2017-06-30 was $35.00K.
  • VYOME HOLDINGS, INC. increase (decrease) in deferred revenue for fiscal 2019 was $72.00K.
  • VYOME HOLDINGS, INC. increase (decrease) in deferred revenue for fiscal 2018 was -$158.00K, a 140.62% decline from fiscal 2017.
  • VYOME HOLDINGS, INC. increase (decrease) in deferred revenue for fiscal 2017 was $389.00K, a 221.49% increase from fiscal 2016.
  • VYOME HOLDINGS, INC. increase (decrease) in deferred revenue for fiscal 2016 was $121.00K.
Period endIncrease (Decrease) in Deferred Revenue 3 monthIncrease (Decrease) in Deferred Revenue 6 monthIncrease (Decrease) in Deferred Revenue 9 monthIncrease (Decrease) in Deferred Revenue 12 month
2019-12-31$72.00K
10-K · filed 2020-02-27
2018-12-31-$158.00K
10-K · filed 2020-02-27
2018-03-31-$173.00K
10-Q · filed 2018-05-10
$144.00K
derived: sum of 2 quarters · filed 2019-02-22
$131.00K
derived: sum of 3 quarters · filed 2019-02-22
$166.00K
derived: sum of 4 quarters · filed 2019-02-22
2017-12-31$317.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22
$304.00K
derived: sum of 2 quarters · filed 2019-02-22
$339.00K
derived: sum of 3 quarters · filed 2019-02-22
$389.00K
10-K · filed 2019-02-22
2017-09-30-$13.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03
$22.00K
derived: sum of 2 quarters · filed 2017-11-03
$72.00K
10-Q · filed 2017-11-03
$193.00K
derived: sum of 4 quarters · filed 2018-05-10
2017-06-30$35.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02
$85.00K
10-Q · filed 2017-08-02
$206.00K
derived: sum of 3 quarters · filed 2018-05-10
$206.00K
derived: sum of 4 quarters · filed 2018-05-10
2017-03-31$50.00K
10-Q · filed 2018-05-10
$171.00K
derived: sum of 2 quarters · filed 2018-05-10
$171.00K
derived: sum of 3 quarters · filed 2018-05-10
$171.00K
derived: sum of 4 quarters · filed 2018-05-10
2016-12-31$121.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05
$121.00K
derived: sum of 2 quarters · filed 2018-03-05
$121.00K
derived: sum of 3 quarters · filed 2018-03-05
$121.00K
10-K · filed 2018-03-05
2016-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03
$0.00
derived: sum of 2 quarters · filed 2017-11-03
$0.00
10-Q · filed 2017-11-03
2016-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02
$0.00
10-Q · filed 2017-08-02
2016-03-31$0.00
10-Q · filed 2017-05-10
2015-12-31$0.00
10-K · filed 2018-03-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36